Promoting cost effective prescribing. Cost effectiveness studies may not be cost effective.
作者信息
Towse A, Wells N
出版信息
BMJ. 1995 Jul 8;311(6997):126. doi: 10.1136/bmj.311.6997.126b.
Abstract
摘要
相似文献
1
Promoting cost effective prescribing. Cost effectiveness studies may not be cost effective.推广具有成本效益的处方开具。成本效益研究本身可能并非具有成本效益。
BMJ. 1995 Jul 8;311(6997):126. doi: 10.1136/bmj.311.6997.126b.
2
Promoting cost effective prescribing. More trials from general practice are needed.推广具有成本效益的处方开具。需要更多来自全科医疗的试验。
BMJ. 1995 Jul 8;311(6997):126. doi: 10.1136/bmj.311.6997.126c.
3
Prescribing.开处方
Practitioner. 1990 Oct;234(1495):888-90.
4
Fundholding and prescribing. Prescribing practice may have been inefficient.基金持有与处方开具。处方开具行为可能一直效率低下。
BMJ. 1995 Jul 8;311(6997):128; author reply 128-9. doi: 10.1136/bmj.311.6997.128b.
5
Fundholding and prescribing. Reorganisation of prescribing practices should not be delayed.基金持有与开处方。开处方业务的重组不应延迟。
BMJ. 1995 Jul 8;311(6997):128. doi: 10.1136/bmj.311.6997.128c.
6
Promoting cost effective prescribing.推广具有成本效益的处方开具。
BMJ. 1995 Apr 15;310(6985):955-6. doi: 10.1136/bmj.310.6985.955.
7
Prescribing data and cost comparisons in New Zealand.
N Z Med J. 1997 Nov 28;110(1056):445-6.
8
Prescribing costs and patterns: authors' response.处方成本与模式：作者回应
Br J Gen Pract. 2002 Jul;52(480):587.
9
Transferring the costs of expensive treatments from secondary to primary care.将昂贵治疗的费用从二级医疗转移至初级医疗。
BMJ. 1995 Feb 25;310(6978):509-12. doi: 10.1136/bmj.310.6978.509.
10
Prescribing costs. Consider national standards for daily dosage.处方成本。考虑每日剂量的国家标准。
BMJ. 1994 Jan 15;308(6922):207. doi: 10.1136/bmj.308.6922.207.
引用本文的文献
1
The UK pharmaceutical market. An overview.英国制药市场。概述。
Pharmacoeconomics. 1996;10 Suppl 2:14-25. doi: 10.2165/00019053-199600102-00005.
本文引用的文献
1
Promoting cost effective prescribing.推广具有成本效益的处方开具。
BMJ. 1995 Apr 15;310(6985):955-6. doi: 10.1136/bmj.310.6985.955.
Zotero 插件